Analysis: in 2024, ~66% of 39 public digital health companies lost value, while the Nasdaq rose 32%; in 2021, digital health startups raised a record $29.1B
Post-pandemic demand waned, bringing down former high fliers like Teladoc (-96% from 2021 highs) and Progyny (-60% YTD). … X: Ashley Capoot / @ashleycapoot : New: It's been nearly 5 years since Covid broke out in the U.S., but digital health companies are still reeling. According to a @CNBC analysis of 39 public digital health companies, around 2/3 have lost value this year, while the Nasdaq is up 32%. More! https://www.cnbc.com/... Paul Sonnier / @paul_sonnier : Digital Health Winners & Losers in the Stock Market for 2024 Losers: Progyny, Teladoc Health, GoodRx, Dexcom, 23andMe, Cue Health, Better Therapeutics Winners: Hims & Hers, Doximity, Oscar Health, Waystar (IPO), Tempus AI (IPO) https://www.cnbc.com/... #DigitalHealth LinkedIn: Ashley Capoot : New: If the Covid era marked a boom time for digital health companies, 2024 was the reckoning. According to a CNBC analysis of 39 public digital health companies …